Ribosomal protein S19 and S24 insufficiency cause distinct cell cycle defects in Diamond-Blackfan anemia.
Diamond-Blackfan anemia (DBA) is a severe congenital anemia characterized by a specific decrease of erythroid precursors. The disease is also associated with growth retardation, congenital malformations, a predisposition for malignant disease and heterozygous mutations in either of the ribosomal protein (RP) genes RPS7, RPS17, RPS19, RPS24, RPL5, RPL11 and RPL35a. We show herein that primary fibroblasts from DBA patients with truncating mutations in RPS19 or in RPS24 have a marked reduction in proliferative capacity. Mutant fibroblasts are associated with extended cell cycles and normal levels of p53 when compared to w.t. cells. RPS19 mutant fibroblasts accumulate in the G1 phase, whereas the RPS24 mutant cells show an altered progression in the S phase resulting in reduced levels in the G2/M phase. RPS19 deficient cells exhibit reduced levels of Cyclin-E, CDK2 and retinoblastoma (Rb) protein supporting a cell cycle arrest in the G1 phase. In contrast, RPS24 deficient cells show increased levels of the cell cycle inhibitor p21 and a seemingly opposing increase in Cyclin-E, CDK4 and CDK6. In combination, our results show that RPS19 and RPS24 insufficient fibroblasts have an impaired growth caused by distinct blockages in the cell cycle. We suggest this proliferative constraint to be an important contributing mechanism for the complex extra-hematological features observed in DBA.
Badhai
Jitendra
J
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Fröjmark
Anne-Sophie
AS
J Davey
Edward
E
Schuster
Jens
J
Dahl
Niklas
N
D029503:Anemia, Diamond-Blackfan / Q000378:metabolism* / Q000473:pathology*; D015153:Blotting, Western; D002453:Cell Cycle; D018797:Cell Cycle Proteins / Q000378:metabolism; D049109:Cell Proliferation; D002478:Cells, Cultured; D015536:Down-Regulation; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D006801:Humans; D009154:Mutation / Q000235:genetics; D012335:RNA, Ribosomal / Q000378:metabolism; D012269:Ribosomal Proteins / Q000378:metabolism*
D018797:Cell Cycle Proteins; D012335:RNA, Ribosomal; C489053:RPS24 protein, human; D012269:Ribosomal Proteins; C040343:ribosomal protein S19
Med Hypotheses. 2006;66(3):643-8
16239073
Am J Med Genet. 2001 Jul 1;101(3):268-74
11424144
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10408-13
18641120
Genetics. 1998 Mar;148(3):1215-24
9539436
Cell Cycle. 2008 Apr 1;7(7):892-8
18414028
Expert Rev Mol Med. 2008 Jul 01;10:e19
18590585
Mol Cell. 2009 Apr 10;34(1):3-11
19362532
Blood. 2005 Jan 15;105(2):838-46
15238419
J Pediatr Hematol Oncol. 2001 Jan;23(1):39-44
11196268
RNA. 2008 Sep;14(9):1918-29
18697920
FEBS Lett. 2009 Jun 18;583(12):2049-53
19454283
Dev Dyn. 2009 Jan;238(1):76-85
19097187
Blood. 2007 Feb 1;109(3):1275-83
17053056
Curr Top Dev Biol. 2008;82:217-41
18282522
Blood. 2008 Dec 15;112(13):5228-37
18515656
Mol Ther. 2003 May;7(5 Pt 1):613-22
12718904
Science. 1992 Sep 18;257(5077):1689-94
1388288
Nat Genet. 1999 Feb;21(2):169-75
9988267
Haematologica. 2006 Nov;91(11):1456-64
17082006
FASEB J. 2007 Nov;21(13):3442-5
17586729
J Cell Sci Suppl. 1994;18:69-73
7883795
Nat Genet. 2008 Aug;40(8):963-70
18641651
Hum Mutat. 2007 Dec;28(12):1178-82
17647292
Am J Hum Genet. 2008 Dec;83(6):769-80
19061985
Stem Cells. 2008 Feb;26(2):323-9
17962699
Nature. 1995 Mar 9;374(6518):131-4
7877684
Cancer. 1995 Aug 1;76(3):517-20
8625135
Hum Mol Genet. 2008 May 1;17(9):1253-63
18230666
Blood. 2008 Sep 1;112(5):1582-92
18535205
Br J Haematol. 2008 Feb;140(3):348-59
18217898
Biochem Biophys Res Commun. 2009 Feb 6;379(2):167-70
19114035
Blood. 1999 Dec 15;94(12):4294-306
10590074
Am J Pediatr Hematol Oncol. 1989 Winter;11(4):380-94
2694854
Blood. 2007 Feb 1;109(3):980-6
16990592
Cell. 2005 Oct 7;123(1):49-63
16213212
Hematology Am Soc Hematol Educ Program. 2007;:29-39
18024606
Br J Haematol. 2008 Sep;142(6):859-76
18671700